Onderzoeker
Jaak JANSSENS
- Trefwoorden:Geneeskunde
- Disciplines:Andere klinische wetenschappen niet elders geclassificeerd
Affiliaties
- Zorg & Ethiek (Departement)
Lid
Vanaf1 jan 2020 → 30 sep 2022 - Zorg & Ethiek (Onderzoeksgroep)
Lid
Vanaf1 jan 2020 → 30 sep 2022 - Biomedisch Onderzoeksinstituut (Onderzoeksinstituut)
Lid
Vanaf15 nov 2006 → 30 sep 2022 - Geneeskunde en Levenswetenschappen (Faculteit)
Lid
Vanaf15 nov 2006 → 30 sep 2022 - Fysiologie - biochemie - immunologie (Departement)
Lid
Vanaf15 nov 2006 → 31 dec 2019 - Medische basiswetenschappen (Afdeling)
Lid
Vanaf15 nov 2006 → 30 sep 2009 - Immunologie - Biochemie (Onderzoeksgroep)
Lid
Vanaf1 sep 1998 → 31 dec 2019
Publicaties
1 - 10 van 12
- Recombinant human chorionic gonadotropin induces signaling pathways towards cancer prevention in the breast of BRCA1/2 mutation carriers(2023)
Auteurs: Yanrong Su, Nhi M. M. Dang, Herman Depypere, Julia Santucci-Pereira, Pedro J. J. Gutierrez-Diez, Joice Kanefsky, Jaak JANSSENS, Jose Russo
Pagina's: 126 - 138 - New leadership for the European Cancer Prevention Organization(2023)
Auteurs: Jaak JANSSENS
Pagina's: 99 - 102 - Prolonged recombinant pregnancy hormone use in BRCA1 and BRCA2 mutation carriers(2021)
Auteurs: Herman Depypere, Yanrong Su, Nhi Dang, Frank Stanczyk, Jaak JANSSENS, Jose Russo, Bruce Poppe
Pagina's: 195 - 203 - SCREENING FOR IMMUNOGLOBULIN A ANTIBODY REACTIVITY IN EARLY AXIAL SPONDYLOARTHRITIS IDENTIFIES NOVEL ANTIGENIC TARGETS(2020)
Auteurs: Patrick VANDORMAEL, Dana QUADEN, Pieter RUYTINX, Jaak JANSSENS, Johan VANHOOF, Piet GEUSENS, Veerle SOMERS
Pagina's: 1916 - 1916 - Treatment choices based on multiplatform profiling platform, unlike those with sequencing alone, do not cause a cost explosion in refractory cancer patients(2017)
Auteurs: K. J. Russell, Jaak JANSSENS, A. Dean, A. Hernandez, A. Voss
Pagina's: A579 - A579 - COMPARISON OF UTILITY COST IN THREE COMMERCIALLY AVAILABLE PRECISION MEDICINE APPROACHES IN ONCOLOGY(2017)
Auteurs: K. J. Russell, Jaak JANSSENS, A. Dean, A. Hernandez, A. Voss
Pagina's: A590 - A590 - Immune response and immunotherapy in intraepithelial and invasive lesions of the uterine cervix(2012)
Auteurs: F. A. Machado, Jaak JANSSENS, M. A. Michelin, E. F. C. Murta
Pagina's: 27 - 31 - IMPACT OF MAMMAPRINT ON THE ROUTINE TREATMENT DECISION MAKING PROCESS IN AN UNSELECTED EARLY BREAST CANCER PATIENT POPULATION IN BELGIUM(2010)
Auteurs: P. G. Cusumano, F. Liebens, B. Carly, G. Jerusalem, E. Lifrange, Jaak JANSSENS, J. VLASSELAER, V. Jossa
Pagina's: 86 - 87 - A RETROSPECTIVE SURVEY OF SYSTEMIC ANTICANCER THERAPY IN WOMEN WITH METASTATIC BREAST CANCER (MBC) IN BELGIUM(2010)
Auteurs: C. Fontaine, Jaak JANSSENS, C. Dopchie, C. Nouwynck
Pagina's: 108 - 108 - Efficacy and safety of direct and frontal macrobiopsies in breast cancer(2009)
Auteurs: Ann Cornelis, Marcel Verjans, Thierry Van den Bosch, Katrien Wouters, Johan Van Robaeys, Jaak JANSSENS
Pagina's: 280 - 284